Product Images Losartan Potassium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Losartan Potassium NDC 68071-1684 by Nucare Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
68071 1684 9
This is a description of a medication produced by NuCare Pharmaceuticals. The medication is Losartan Potassium 25mg and it comes in a bottle containing 90 tablets. The manufacturer's NDC is 13668-113-90 and the lot number is 000000. The medication may have side effects, and consumers are advised to consult their doctor in such an event. The medication should be stored within a controlled temperature range, i.e. between 59-86°F. The expiration date is not available.*
Figure 1 - 92296151 e507 41b4 a040 c01b87ecb982 01
figure 2 - 92296151 e507 41b4 a040 c01b87ecb982 02
This text appears to be a chart or a graph related to a study conducted involving two medications: ion Atenolol and Losartan Potassium Tablets. The chart also displays percentages of patients who achieved the primary endpoint, along with adjusted risk reduction percentage values and study months ranging from 0 to 60 with an additional value of 65. It is unclear what the primary endpoint is or what the study was about.*
figure 3 - 92296151 e507 41b4 a040 c01b87ecb982 03
The text is describing a comparison between two medications, Atenolol and Losartan Potassium Tablets, in terms of their effect on patients with fatal or non-fatal stroke. The data shows the percentage of patients experiencing stroke over a period of 68 study months. The medications are compared based on their adjusted risk reduction, which was found to be 25% with a p-value of 0.001.*
figure 4 - 92296151 e507 41b4 a040 c01b87ecb982 04
figure 5 - 92296151 e507 41b4 a040 c01b87ecb982 05
The text suggests a clinical trial involving patients taking Losartan Potassium tablets and placebo. It indicates that there were different percentages of patients with an unknown event, and that the risk reduction was 16.1% with a value of 0.022. However, without more information about the trial or what the event is, it is difficult to provide a more specific description of the results.*
figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 06
figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 07
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.